Back to Search
ADRIENNE CLAMP, MD
MD
Family Medicine Physician
NPI: 1720124670Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0101227782(VA)
Research & Publications (20)
Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells.
PMID 19561552·Melanoma Res·2011
8-other
Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma.
PMID 18594529·Br J Cancer·2008
2-rct
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.
PMID 17520255·Cancer Chemother Pharmacol·2008
3-trial
Weekly paclitaxel in the treatment of recurrent ovarian carcinoma.
PMID 17624081·Eur J Gynaecol Oncol·2007
8-other
Heparan sulphate synthetic and editing enzymes in ovarian cancer.
PMID 17437011·Br J Cancer·2007
4-observational
The neoadjuvant approach in the treatment of patients with advanced epithelial ovarian carcinoma.
PMID 17355108·Clin Oncol (R Coll Radiol)·2007
8-other
The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate.
PMID 16481316·J Biol Chem·2006
7-preclinical
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer.
PMID 16404360·Br J Cancer·2006
3-trial
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
PMID 16569491·Eur J Surg Oncol·2006
8-other
A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis.
PMID 17105373·Expert Opin Ther Targets·2006
6-review
Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium.
PMID 15958608·Clin Cancer Res·2005
8-other
Profiling heparan sulfate proteoglycans in ovarian carcinoma.
PMID 15798883·ScientificWorldJournal·2005
8-other
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.
PMID 16222310·Br J Cancer·2005
3-trial
Heparin octasaccharides inhibit angiogenesis in vivo.
PMID 16299249·Clin Cancer Res·2005
7-preclinical
The clinical potential of antiangiogenic fragments of extracellular matrix proteins.
PMID 16234821·Br J Cancer·2005
6-review
A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer.
PMID 15385119·Gynecol Oncol·2004
3-trial
Assessment of therapeutic response in patients with metastatic bone disease.
PMID 15465464·Lancet Oncol·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6862 ELM ST, SUITE 720
MC LEAN, VA 22101 - Phone
- (703) 635-2158
Quick Facts
- NPI
- 1720124670
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile